Specific toxicity of tunicamycin in induction of programmed cell death of sympathetic neurons

Experimental Neurology

Volumn 137, Issue 2, 1996, Pages 201-211

  Chang, Jason Y ^a   Korolev, Vladimir V ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYCLOHEXIMIDE; PROTEIN SYNTHESIS INHIBITOR; TUNICAMYCIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE;

EID: 0029935762     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0019     Document Type: Article

References (37)

1. LEVI-MONTALCINI, R. 1987. The nerve growth factor 35 years later. Science 237: 1154-1162.
2. DECKWERTH, T. L., AND E. M. JOHNSON. 1993. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol. 123(5): 1207-1222.
3. EDWARDS, S. N., AND A. M. TOLKOVSKY. 1994. Characterization of apoptosis in cultured rat sympathetic neurons after nerve growth factor withdrawal. J. Cell Biol. 124(4): 537-546.
4. MARTIN, D. P., R. E. SCHMIDT, P. S. DISTEFANO, O. H. LOWRY, J. G. CARTER, AND E. J. JOHNSON. 1988. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J. Cell Biol. 106(3): 829-844.
5. RYDEL, R. E., AND L. A. GREENE. 1988. cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc. Natl. Acad. Sci. USA 85(4): 1257-1261.
6. 2+ determine nerve growth factor dependence of sympathetic ganglion cells. Proc. Natl. Acad. Sci. USA 86(16): 6421-6425.
7. ELBEIN, A. D. 1987. Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annu. Rev. Biochem. 56: 497-534.
8. DUKSIN, D., M. SEIBERG, AND W. C. MAHONEY. 1982. Inhibition of protein glycosylation and selective cytotoxicity toward virally transformed fibroblasts caused by B3-tunicamycin. Eur. J. Biochem. 129: 77-80.
9. MORIN, M. J., AND R. J. BERNACKI. 1983. Biochemical effects and therapeutic potential of tunicamycin in murine L1210 leukemia. Cancer Res. 43: 1669-1674.
10. KOHSAKA, S., K. MITA, M. MATSUYAMA, M. MIZUNO, AND Y. TSUKADA. 1985. Impaired development of rat cerebellum induced by neonatal injection of the glycoprotein synthesis inhibitor, tunicamycin. J. Neurochem. 44: 406-410.
11. BOURKE, C. A., AND M. J. CARRIGAN. 1993. Experimental tunicamycin toxicity in cattle, sheep and pigs. Aust. Vet. J. 70(5): 188-189.
12. LEAVER, D. D., K. M. SCHNEIDER, M. J. RAND, R. M. ANDERSON, P. W. GAGE, AND R. MALBON. 1988. The neurotoxicity of tunicamycin. Toxicology 49(1): 179-187.
13. FINNIE, J. W., AND J. D. O'SHEA. 1988. Pathological and pathogenetic changes in the central nervous system of guinea pigs given tunicamycin. Acta Neuropathol. 75(4): 411-421.
14. VOGEL, P., AND A. S. MCWILLIAM. 1987. The neurological effects of tunicamycin may reduce its potential as an anticancer agent. Med. J. Aust. 146: 53.
15. GROB, P. M., C. H. BERLOT, AND M. A. BOTHWELL. 1983. Affinity labeling and partial purification of nerve growth factor receptors from rat pheochromocytoma and human melanoma cells. Proc. Natl. Acad. Sci. USA 80: 6819-6823.
16. MARTIN, Z. D., R. OSKAM, G. MITRA, T. COPELAND, AND M. BARBACID. 1989. Molecular and biochemical characterization of the human trk proto-oncogene. Mol. Cell. Biol. 9(1): 24-33.
17. BARIBAULT, T. J., AND K. E. NEET. 1985. Effects of tunicamycin on NGF binding and neurite outgrowth in PC12 cells. J. Neurosci. Res. 14: 49-60.
18. TOLKOVSKY, A. M. 1987. Newly synthesized catalytic and regulatory components of adenylate cyclase are expressed in neurites of cultured sympathetic neurons. J. Neurosci. 7(1): 110-119.
19. FENTON, E. L. 1970. Tissue culture assay of nerve growth factor and of specific antiserum. Exp. Cell Res. 59: 383-392.
20. CHANG, J. Y., D. P. MARTIN, AND E. M. JOHNSON. 1990. Interferon suppresses sympathetic neuronal cell death caused by nerve growth factor deprivation. J. Neurochem. 55(2): 436-445.
21. EDWARDS, S. N., A. E. BUCKMASTER, AND A. M. TOLKOVSKY. 1991. The death programme in cultured sympathetic neurons can be suppressed at the posttranslational level by nerve growth factor, cyclic AMP, and depolarization. J. Neurochem. 57(6): 2140-2143.
22. MARTIN, D. P., A. ITO, K. HORIGOME, P. A. LAMPE, AND E. M. JOHNSON. 1992. Biochemical characterization of programmed cell death in NGF-deprived sympathetic neurons. J. Neurobiol. 23(9): 1205-1220.
23. ANGELETTI, P. U., R. LEVI-MONTALCINI, AND F. CARAMIA. 1971. Analysis of the effects of the antiserum to the nerve growth factor in adult mice. Brain Res. 27: 343-355.
24. LAZARUS, K J., R. A. BRADSHAW, N. R. WEST, AND R. P. BUNGE. 1976. Adaptive survival of rat sympathetic neurons cultured without supporting cells or exogenous nerve growth factor. Brain Res. 113: 159-164.
25. PRIVES, J., AND D. BAR-SAGI. 1983. Effect of tunicamycin, an inhibitor of protein glycosylation, on the biological properties of acetylcholine receptors in cultured muscle cells. J. Biol. Chem. 258(3): 1775-1780.
26. GIOVANNELLI, A., F. GRASSI, F. EUSEBI, AND R. MILEDI. 1991. Tunicamycin increases desensitization of acetylcholine receptors in cultured mouse muscle cells. Proc. Natl. Acad. Sci. USA 88: 1808-1811.
27. SEMMES, O. J., M. S. SZTEIN, J. M. BAILEY, AND W. D. MERRITT. 1992. Tunicamycin inhibits function and expression of the high-affinity IL-2 receptor in a murine IL-2-dependent cell line. Int. J. Immunopharmacol. 14(4): 583-593.
28. NAGAO, M., S. MATSUMOTO, S. MASUDA, AND R. SASAKI. 1993. Effect of tunicamycin treatment on ligand binding to the erythropoietin receptor: Conversion from two classes of binding sites to a single class. Blood 81(10): 2503-2510.
29. SZECOWKA, J., L. TAI, AND H. M. GOODMAN. 1990. Effects of tunicamycin on growth hormone binding in rat adipocytes. Endocrinology 126(4): 1834-1841.
30. HEACOCK, A. M. 1982. Glycoprotein requirement for neurite outgrowth in goldfish retina explant: Effects of tunicamycin. Brain Res. 241: 307-315.
31. RICHTER-LANDSBERG, C., AND D. DUKSIN. 1983. Role of glycoproteins in neuronal differentiation. Exp. Cell Res. 149: 335-345.
32. PATTERSON, S. I., AND J. H. P. SKENE. 1994. Novel inhibitory action of tunicamycin homologues suggests a role of dynamic protein fatty acylation in growth cone-mediated neurite extension. J. Cell Biol. 124(4): 521-536.
33. BALDWIN, A. N., AND E. M. SHOOTER. 1995. Zone mapping of the binding domain of the rat low affinity nerve growth factor receptor by the introduction of novel N-glycosylation sites. J. Biol. Chem. 270(9): 4594-4602.
34. ZANELLATO, A., L. FACCI, L. PETRELLI, R. TASO, AND S. D. SKAPER. 1994. Characterization and growth-dependent regulation of the nerve growth factor receptor gp140-trk in rat C6 glioma cells. Mol. Brain Res. 23: 299-309.
35. VOGEL, P., B. A. STYNES, W. COACKLEY, G. T. YEOH, AND D. S. PETERSON. 1982. Glycolipid toxins from parasitised annual ryegrass: A comparison with tunicamycin. Biochem. Biophys. Res. Commun. 105(3): 835-840.
36. VOGEL, P., B. A. STYNES, AND W. COACKLEY. 1983. Corynetoxins, the causal agents of annual ryegrass toxicity shown to be closely related to the antibiotic tunicamycin. Toxicon 21(Suppl. 3): 477-480.
37. JAGO, M. V., AND C. C. CULVENOR. 1987. Tunicamycin and corynetoxin poisoning in sheep. Aust. Vet. J. 64(8): 232-235.